Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-04 Purchase | 2025-02-05 3:17 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,000 | $3.1 | $3,100 | 155,793 (Direct) | View |
| 2025-02-04 Purchase | 2025-02-04 5:05 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,000 | $2.98 | $2,980 | 154,793 (Direct) | View |
| 2024-12-20 Purchase | 2025-01-29 5:26 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,000 | $2.75 | $2,750 | 411,793 (Direct) | View |
| 2025-01-28 Purchase | 2025-01-29 5:22 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,500 | $2.7 | $4,050 | 153,793 (Direct) | View |
| 2025-01-13 Purchase | 2025-01-24 4:55 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 3,000 | $2.5667 | $7,700 | 152,293 (Direct) | View |
| 2024-10-28 Purchase | 2024-10-30 10:55 am | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 500 | $2.19 | $1,095 | 148,293 (Direct) | View |
| 2024-08-13 Purchase | 2024-08-15 4:25 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,000 | $0.95 | $950 | 147,793 (Direct) | View |
| 2024-06-28 Purchase | 2024-07-01 1:47 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,000 | $1.75 | $1,750 | 146,793 (Direct) | View |
| 2024-06-18 Purchase | 2024-06-21 11:21 am | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 1,619 | $0.71 | $1,149 | 145,793 (Direct) | View |
| 2024-06-10 Purchase | 2024-06-12 1:19 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 3,000 | $0.64 | $1,920 | 144,174 (Direct) | View |
| 2022-09-16 Purchase | 2022-09-20 2:05 pm | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 2,500 | $4.15 | $10,375 | 141,174 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-26 Option Award | 2025-02-27 4:33 pm | 2025-02-26 2033-06-30 | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 919,184 | $0 | 1,853,189 (Direct) | View |
| 2024-11-07 Ownership | 2025-01-29 5:26 pm | 2024-11-07 2029-08-26 | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 262,500 | $0 | 411,793 (Direct) | View |
Ownership | 2022-09-19 5:03 pm | N/A N/A | Nexalin Technology Inc. | NXL | Owens David Chief Medical Officer | 0 | $0 | 138,674 (Direct) | View |